Yes, phagocytes can be leveraged in cancer therapy. Strategies include enhancing their ability to recognize and destroy cancer cells, as well as manipulating the tumor microenvironment to reduce their tumor-supporting activities. For instance, blocking the CD47 signal can make cancer cells more susceptible to phagocytosis. Another approach involves using checkpoint inhibitors to activate phagocytes against tumors.
